IL103778A - Organic salts of N,N'-diacetyl cystine process for their preparation and pharmaceutical compositions containing them - Google Patents
Organic salts of N,N'-diacetyl cystine process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL103778A IL103778A IL10377892A IL10377892A IL103778A IL 103778 A IL103778 A IL 103778A IL 10377892 A IL10377892 A IL 10377892A IL 10377892 A IL10377892 A IL 10377892A IL 103778 A IL103778 A IL 103778A
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- organic salts
- diacetyl cystine
- Prior art date
Links
- YTPQSLLEROSACP-YUMQZZPRSA-N (2R)-2-acetamido-3-[[(2R)-2-acetamido-2-carboxyethyl]disulfanyl]propanoic acid Chemical class CC(=O)N[C@H](C(O)=O)CSSC[C@@H](C(O)=O)NC(C)=O YTPQSLLEROSACP-YUMQZZPRSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/22—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of hydropolysulfides or polysulfides
- C07C319/24—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of hydropolysulfides or polysulfides by reactions involving the formation of sulfur-to-sulfur bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
- C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9103572A SE9103572D0 (sv) | 1991-11-29 | 1991-11-29 | Organic salts of n,n'-diacetyl cystine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL103778A0 IL103778A0 (en) | 1993-04-04 |
| IL103778A true IL103778A (en) | 1997-08-14 |
Family
ID=20384494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10377892A IL103778A (en) | 1991-11-29 | 1992-11-17 | Organic salts of N,N'-diacetyl cystine process for their preparation and pharmaceutical compositions containing them |
Country Status (38)
| Country | Link |
|---|---|
| US (5) | US5385904A (xx) |
| EP (1) | EP0621862B1 (xx) |
| JP (1) | JP3302018B2 (xx) |
| KR (1) | KR100256185B1 (xx) |
| CN (1) | CN1039586C (xx) |
| AP (1) | AP350A (xx) |
| AT (1) | ATE141913T1 (xx) |
| AU (1) | AU657827B2 (xx) |
| CA (1) | CA2123516A1 (xx) |
| CZ (1) | CZ282085B6 (xx) |
| DE (1) | DE69213256T2 (xx) |
| DK (1) | DK0621862T3 (xx) |
| DZ (1) | DZ1637A1 (xx) |
| EE (1) | EE03025B1 (xx) |
| ES (1) | ES2090713T3 (xx) |
| FI (1) | FI942504A0 (xx) |
| GR (1) | GR3021546T3 (xx) |
| HK (1) | HK62297A (xx) |
| HR (1) | HRP921322B1 (xx) |
| HU (1) | HU215390B (xx) |
| IL (1) | IL103778A (xx) |
| IS (1) | IS1645B (xx) |
| LV (1) | LV11949B (xx) |
| MA (1) | MA22716A1 (xx) |
| MX (1) | MX9206851A (xx) |
| MY (1) | MY110523A (xx) |
| NO (1) | NO301325B1 (xx) |
| NZ (1) | NZ245077A (xx) |
| PL (2) | PL171336B1 (xx) |
| RU (1) | RU2135468C1 (xx) |
| SE (1) | SE9103572D0 (xx) |
| SG (1) | SG73962A1 (xx) |
| SI (1) | SI9200351A (xx) |
| SK (1) | SK281697B6 (xx) |
| TN (1) | TNSN92108A1 (xx) |
| WO (1) | WO1993011104A1 (xx) |
| YU (1) | YU48594B (xx) |
| ZA (1) | ZA928739B (xx) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3865463A (en) * | 1973-11-12 | 1975-02-11 | Busch & Co Inc Ag | Electrical adapter plug |
| ES2092539T3 (es) * | 1991-01-10 | 1996-12-01 | Transcend Therapeutics Inc | Uso de derivados de la tiazolidina-4-carboxilato para el tratamiento de enfermedades pulmonares. |
| US5747459A (en) * | 1991-02-04 | 1998-05-05 | Nestec, Ltd. | Method for insuring adequate intracellular glutathione in tissue |
| US5430045A (en) * | 1992-04-23 | 1995-07-04 | Free Radical Sciences, Inc. | Method of reducing or preventing bone marrow hypoplasia |
| US5447712A (en) * | 1993-12-09 | 1995-09-05 | Free Radical Sciences | Method of reducing cyclophosphamide induced hemorrhagic cystitis |
| SE9500897D0 (sv) * | 1995-03-14 | 1995-03-14 | Astra Ab | The pharmacological use of certain cystine derivatives |
| SE9602262D0 (sv) * | 1996-06-06 | 1996-06-06 | Astra Ab | New use of derivatives of cystine |
| AR007398A1 (es) * | 1996-06-18 | 1999-10-27 | Astrazeneca Ab | Proceso para preparar sales inorganicas de n-n'-diacetilcistina |
| SE9602416D0 (sv) * | 1996-06-18 | 1996-06-18 | Astra Ab | New forms of an organic salt of N'N-diacetylcystine |
| US6017959A (en) * | 1996-06-18 | 2000-01-25 | Astra Aktiebolag | Forms of organic salts of N,N'-diacetylcystine |
| CN1059907C (zh) * | 1997-05-23 | 2000-12-27 | 中国石油化工集团公司巴陵石化岳阳石油化工总厂 | 一种含共轭二烯轻聚合物的选择氢化方法 |
| US20030203006A1 (en) * | 1997-10-29 | 2003-10-30 | Ajinomoto Co. Inc. | Immunomodulator |
| US6197749B1 (en) * | 1997-10-29 | 2001-03-06 | Ajinomoto Co., Inc. | Method of suppressing immune responses by reducing intracellular content of glutathione in macrophages and monocytes |
| SE9800932D0 (sv) * | 1998-03-20 | 1998-03-20 | Astra Ab | New compunds |
| EP1004302A3 (en) * | 1998-10-29 | 2003-06-04 | Ajinomoto Co., Inc. | Immunomodulator |
| SE9900438D0 (sv) * | 1999-02-10 | 1999-02-10 | Astra Ab | The pharmacological use of certian cystine derivatives |
| US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| SE518784C2 (sv) * | 2000-12-27 | 2002-11-19 | Nactilus Ab | "N-Acetyl-L-cystein med kompositioner för behandling av neoplasier" |
| WO2002072040A1 (fr) * | 2001-03-13 | 2002-09-19 | Ajinomoto Co., Inc. | Produits cosmetiques ou preparations a usage externe pour la peau |
| DE60318938T2 (de) | 2002-03-20 | 2009-01-22 | Mannkind Corp., Valencia | Inhalationsgerät |
| DK1786784T3 (da) | 2004-08-20 | 2011-02-14 | Mannkind Corp | Katalyse af diketopiperazinsyntese |
| JP4990142B2 (ja) | 2004-08-23 | 2012-08-01 | マンカインド コーポレイション | 薬物送達のためのジケトピペラジン塩、ジケトモルホリン塩、又はジケトジオキサン塩 |
| HUE028691T2 (en) | 2005-09-14 | 2016-12-28 | Mannkind Corp | A method for formulating a drug based on increasing the affinity of crystalline microparticle surfaces towards active ingredients |
| AU2007216966C1 (en) | 2006-02-22 | 2014-03-20 | Mannkind Corporation | A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
| US8438729B2 (en) * | 2006-03-09 | 2013-05-14 | Canon Kabushiki Kaisha | Method of producing liquid discharge head |
| ES2655921T3 (es) | 2008-06-13 | 2018-02-22 | Mannkind Corporation | Un inhalador de polvo seco y sistema para administración de fármacos |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| ES2904623T3 (es) | 2008-06-20 | 2022-04-05 | Mannkind Corp | Aparato interactivo para establecer un perfil en tiempo real de esfuerzos de inhalación |
| TWI532497B (zh) | 2008-08-11 | 2016-05-11 | 曼凱公司 | 超快起作用胰島素之用途 |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| EP2405963B1 (en) | 2009-03-11 | 2013-11-06 | MannKind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
| WO2010144789A2 (en) | 2009-06-12 | 2010-12-16 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
| WO2011056889A1 (en) | 2009-11-03 | 2011-05-12 | Mannkind Corporation | An apparatus and method for simulating inhalation efforts |
| KR20130117755A (ko) | 2010-06-21 | 2013-10-28 | 맨카인드 코포레이션 | 건조 분말 약물 운반 시스템 및 방법 |
| CN105667994B (zh) | 2011-04-01 | 2018-04-06 | 曼金德公司 | 用于药物药盒的泡罩包装 |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| WO2013063160A1 (en) | 2011-10-24 | 2013-05-02 | Mannkind Corporation | Methods and compositions for treating pain |
| CN102491926B (zh) * | 2011-12-15 | 2013-09-25 | 青岛市药品检验所 | 一种硫普罗宁二硫化物的制备和纯化方法 |
| CN108057154B (zh) | 2012-07-12 | 2021-04-16 | 曼金德公司 | 干粉药物输送系统和方法 |
| US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
| JP6523247B2 (ja) | 2013-03-15 | 2019-05-29 | マンカインド コーポレイション | 微結晶性ジケトピペラジン粒子の製造方法および乾燥粉末組成物の製造方法 |
| EP3021834A1 (en) | 2013-07-18 | 2016-05-25 | MannKind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
| EP3030294B1 (en) | 2013-08-05 | 2020-10-07 | MannKind Corporation | Insufflation apparatus |
| US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
| WO2021219376A1 (en) * | 2020-04-28 | 2021-11-04 | Unilever Ip Holdings B.V. | Personal care compositions with enhanced solubility actives |
| WO2022067248A1 (en) * | 2020-09-28 | 2022-03-31 | Georgia Tech Research Corporation | Use of cystine and derivatives thereof as anti-thrombotic and thrombolytic agents |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB592631A (en) * | 1945-04-04 | 1947-09-24 | Du Pont | Cysteine and cystine |
| GB954268A (en) | 1962-02-26 | 1964-04-02 | Mead Johnson & Co | Decongestant compositions comprising n-acylated sulphydryl compounds |
| FR8205M (xx) * | 1968-12-20 | 1970-09-14 | ||
| US3647834A (en) | 1969-08-11 | 1972-03-07 | Mead Johnson & Co | Zinc mercaptide n-acetylcysteine carboxylate salts |
| US3878305A (en) | 1972-05-25 | 1975-04-15 | Procter & Gamble | Fortification of foodstuffs with n-acyl derivatives of sulphur-containing l-amino acids |
| US3952115A (en) * | 1975-04-02 | 1976-04-20 | The Procter & Gamble Company | Fortification of foodstuffs with N-acyl derivatives of sulfur-containing L-amino acid esters |
| US4141734A (en) * | 1975-09-11 | 1979-02-27 | Ciba-Geiby Ag | Photographic developing process |
| US4093739A (en) * | 1977-06-15 | 1978-06-06 | Mead Johnson & Company | Mercaptoacylamidobenzoyl glycine and mucolytic process |
| JPS6011888B2 (ja) * | 1978-10-11 | 1985-03-28 | 参天製薬株式会社 | リウマチ疾患治療薬 |
| JPS56155298A (en) | 1980-05-02 | 1981-12-01 | Tanabe Seiyaku Co | Shampoo composition |
| GB2097256B (en) * | 1981-04-02 | 1985-05-30 | Morelle Jean V | Compositions containing n-butyryl alphaaminoacids |
| FR2503151A1 (fr) * | 1981-04-02 | 1982-10-08 | Morelle Jean | Butyryminoacides soufres. mode de preparation. emploi comme element keratogenique chez l'homme et l'animal et comme agent de fertilisation chez les vegetaux |
| JPS58164566A (ja) * | 1982-03-09 | 1983-09-29 | Kenji Okawa | シスチン類の製造法 |
| US4827016A (en) * | 1985-09-16 | 1989-05-02 | Morgan Lee R | Method and compounds for reducing dermal inflammations |
| US4708965A (en) | 1985-09-16 | 1987-11-24 | Morgan Lee R | Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives |
| US4724239A (en) * | 1985-09-16 | 1988-02-09 | Morgan Lee R | Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine |
| JPH0660157B2 (ja) * | 1985-11-20 | 1994-08-10 | 三井東圧化学株式会社 | システインからシスチンを製造する方法 |
| JPS62195356A (ja) * | 1986-02-20 | 1987-08-28 | Seiwa Kasei:Kk | シスチン誘導体及びその塩 |
| AT402931B (de) * | 1986-11-07 | 1997-09-25 | Pharmacia Gmbh | Verfahren zur herstellung von neuen cystinverbindungen und derenverwendung |
| SE8704542D0 (sv) * | 1987-11-19 | 1987-11-19 | Draco Ab | New derivatives of cysteine |
| IL98310A (en) * | 1990-06-08 | 1996-08-04 | Astra Ab | Medicinal preparations containing a history of cystine |
| TW221376B (xx) * | 1990-06-28 | 1994-03-01 | Astra Ab | |
| GB9111885D0 (en) * | 1991-06-03 | 1991-07-24 | Erba Carlo Spa | Nerve growth factor for use in the prevention and treatment of viral infections |
-
1991
- 1991-11-29 SE SE9103572A patent/SE9103572D0/xx unknown
-
1992
- 1992-11-10 NZ NZ245077A patent/NZ245077A/en unknown
- 1992-11-12 ZA ZA928739A patent/ZA928739B/xx unknown
- 1992-11-17 IL IL10377892A patent/IL103778A/xx not_active IP Right Cessation
- 1992-11-18 YU YU99092A patent/YU48594B/sh unknown
- 1992-11-20 AP APAP/P/1992/000448A patent/AP350A/en active
- 1992-11-23 HR HR9103572-5A patent/HRP921322B1/xx not_active IP Right Cessation
- 1992-11-23 TN TNTNSN92108A patent/TNSN92108A1/fr unknown
- 1992-11-24 MA MA23006A patent/MA22716A1/fr unknown
- 1992-11-24 IS IS3949A patent/IS1645B/is unknown
- 1992-11-25 MY MYPI92002155A patent/MY110523A/en unknown
- 1992-11-25 ES ES92924975T patent/ES2090713T3/es not_active Expired - Lifetime
- 1992-11-25 EP EP92924975A patent/EP0621862B1/en not_active Expired - Lifetime
- 1992-11-25 DZ DZ920148A patent/DZ1637A1/fr active
- 1992-11-25 SK SK632-94A patent/SK281697B6/sk unknown
- 1992-11-25 DK DK92924975.3T patent/DK0621862T3/da active
- 1992-11-25 PL PL92314567A patent/PL171336B1/pl unknown
- 1992-11-25 PL PL92303924A patent/PL170787B1/pl unknown
- 1992-11-25 HU HU9401473A patent/HU215390B/hu not_active IP Right Cessation
- 1992-11-25 US US07/981,373 patent/US5385904A/en not_active Expired - Lifetime
- 1992-11-25 SG SG1996004497A patent/SG73962A1/en unknown
- 1992-11-25 DE DE69213256T patent/DE69213256T2/de not_active Expired - Fee Related
- 1992-11-25 CA CA002123516A patent/CA2123516A1/en not_active Abandoned
- 1992-11-25 AU AU30996/92A patent/AU657827B2/en not_active Ceased
- 1992-11-25 RU RU94027569/04A patent/RU2135468C1/ru not_active IP Right Cessation
- 1992-11-25 KR KR1019940701815A patent/KR100256185B1/ko not_active IP Right Cessation
- 1992-11-25 CZ CZ941297A patent/CZ282085B6/cs not_active IP Right Cessation
- 1992-11-25 JP JP51003993A patent/JP3302018B2/ja not_active Expired - Fee Related
- 1992-11-25 AT AT92924975T patent/ATE141913T1/de not_active IP Right Cessation
- 1992-11-25 WO PCT/SE1992/000807 patent/WO1993011104A1/en active IP Right Grant
- 1992-11-27 MX MX9206851A patent/MX9206851A/es not_active IP Right Cessation
- 1992-11-28 CN CN92113666A patent/CN1039586C/zh not_active Expired - Fee Related
- 1992-11-30 SI SI19929200351A patent/SI9200351A/sl unknown
-
1994
- 1994-05-26 NO NO941968A patent/NO301325B1/no not_active IP Right Cessation
- 1994-05-27 FI FI942504A patent/FI942504A0/fi unknown
- 1994-11-08 US US08/335,941 patent/US5693858A/en not_active Expired - Fee Related
- 1994-11-17 EE EE9400378A patent/EE03025B1/xx not_active IP Right Cessation
-
1995
- 1995-06-07 US US08/476,218 patent/US5650538A/en not_active Expired - Lifetime
- 1995-06-07 US US08/484,143 patent/US5824681A/en not_active Expired - Fee Related
- 1995-06-07 US US08/477,387 patent/US5804582A/en not_active Expired - Fee Related
-
1996
- 1996-11-06 GR GR960402920T patent/GR3021546T3/el unknown
-
1997
- 1997-05-08 HK HK62297A patent/HK62297A/xx not_active IP Right Cessation
- 1997-08-28 LV LVP-97-158A patent/LV11949B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL103778A (en) | Organic salts of N,N'-diacetyl cystine process for their preparation and pharmaceutical compositions containing them | |
| IL107771A0 (en) | Pharmaceutical compositions containing isothiourea derivatives certain such novel compounds and their preparation | |
| HK1005136A1 (en) | Amido-3-pyrazole derivatives process for their preparation and pharmaceutical compositions containing them | |
| IL103126A (en) | 5-amino-4-hydroxyhexanoic acid derivatives, process for their preparation and pharmaceutical compositions containing them | |
| IL84944A (en) | Pharmaceutical compositions containing 1,2-dihydro-3h-indazolone derivatives,some new such compounds and their preparation | |
| IL102759A0 (en) | Hydantoin derivatives,their preparation and pharmaceutical compositions containing them | |
| IL98756A0 (en) | Pharmaceutical compositions containing benzeneacetamid derivatives,certain such novel compounds and their preparation | |
| IL103516A0 (en) | Cytotoxic bicyclo(7,3,1)tridec-4-ene-2,6-diyne compounds,process for the preparation thereof and pharmaceutical compositions containing them | |
| IL103293A0 (en) | Substituted imidazolyl-propenoic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| HUT66234A (en) | Process to prepare 4,13-dioxabicyclo(8.2.1)-tridecenon-derivatives and pharmaceutical compositions containing them | |
| IL98223A0 (en) | Pharmaceutical compositions containing fluorene derivatives,some such novel compounds and their preparation | |
| HU900746D0 (en) | Process for preparation of 2,3,23-trihydroxy-urz-12-en and it's derivatives and for pharmaceutical compositions containing that compounds | |
| HU895241D0 (en) | Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient | |
| IL105391A0 (en) | 1,2,4-benzothiadiazine-3-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| IL108930A0 (en) | 2,3-Diamino-3- hydroxycarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them | |
| NZ237442A (en) | 1,6,7,9-tetrahydroxy-11-oxolabdane derivatives; their preparation and pharmaceutical compositions | |
| HU9201117D0 (en) | Substituted 2',3'-didezoxy-5-trifluor-methyl-uridine, and process for the production of medical preparations containing such compounds | |
| PL286188A1 (en) | Method of obtaining renine retarding aminooligohydroxy derivatives | |
| IL100393A0 (en) | 15-nitro-2beta,3beta-dihydro-and 15-nitro-2beta,3beta,6,7-tetrahydrotabersonine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL90865A0 (en) | Pharmaceutical compositions containing 1,4-diazepine derivatives,certain such novel compounds and their preparation | |
| IL91864A0 (en) | Pharmaceutical compositions containing 4-bitrophenyl-dihydropyridine amides,certain such novel compounds and their preparation | |
| FI942675A0 (fi) | Uudet substituoidut oksatsinoisokinoliinijohdannaiset, niitä sisältävät farmaseuttiset koostumukset sekä menetelmä niiden valmistamiseksi | |
| IL103497A0 (en) | Pharmaceutical compositions containing substituted tetrahydrothiophenes,certain such novel compounds and their preparation | |
| HUT61776A (en) | Process for producing 3' and/or 4' oh-modificated elsamycin derivatives and pharmaceutical compositions containing them as active components | |
| HUT54682A (en) | Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |